Mission Street and BentallGreenOak (BGO) have received planning consent for 64,400 sq ft of life science facilities at The Press development in Cambridge.
The new facilities, which will create lab and office space either as a headquarters building or up to 6 smaller suites, will form part of a wider 100,000 sq ft development that is transforming a 7.8-acre site into a science and innovation campus.
Situated in the Cambridge Southern Cluster, the region with the largest critical mass of life sciences companies in the UK, the site also benefits from direct rail links to Cambridge Central, Cambridge Biomedical Campus (from 2025) and London King’s Cross.
Construction is due to commence this summer with completion in mid-2024.
This will follow Phase One which is under construction and is due to provide two fitted lab and office suites totalling 16,000 sq ft later this year.
Artem Korolev, founder and chief executive officer of Mission Street, said: “We are thrilled to receive planning consent for Phase Two of The Press. Securing the consent under delegated powers is testament to the enormous effort Mission Street and our professional team have put into engaging with the local community and wider stakeholders.
We are proud to be delivering a scheme that genuinely provides benefits at a local level, whilst addressing the chronic undersupply of high-quality lab and office space that is much needed in the Cambridge ecosystem.”
© Eastern Echo (powered by ukpropertyforums.com).
Sign up to receive our weekly free journal, The Forum here.